Leia mais sobre envelhecimento ativo, tendências e eventos culturais em Belo Horizonte. Conheça o movimento NOLT e a ...
Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...
Danish pharmaceutical company Novo Nordisk A/S has raised 4 billion euros ($4.7 billion) through the sale of bonds to finance the acquisition of American biotech company Akero Therapeutics Inc. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback